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In mental health, the term dual-diagnosis is used for the co-occurrence of Substance
Use Disorder (SUD) with another mental disorder. These co-occurring disorders can
have a shared cause, and can cause/intensify each other’s expression. Forming a threat
to health and society, dual-diagnosis is associated with relapses in addiction-related
behavior and a destructive lifestyle. This is due to a persistent failure to control impulses
and the maintaining of inadequate self-regulatory behavior in daily life. Thus, several
aspects of executive functioning like inhibitory, shifting and updating processes seem
impaired in dual-diagnosis. Executive (dys-)function is currently even seen as a shared
underlying key component of most mental disorders. However, the number of studies
on diverse aspects of executive functioning in dual-diagnosis is limited. In the present
review, a systematic overview of various aspects of executive functioning in dual-
diagnosis is presented, striving for a prototypical profile of patients with dual-diagnosis.
Looking at empirical results, inhibitory and shifting processes appear to be impaired for
SUD combined with schizophrenia, bipolar disorder or cluster B personality disorders.
Studies involving updating process tasks for dual-diagnosis were limited. More research
that zooms in to the full diversity of these executive functions is needed in order to
strengthen these findings. Detailed insight in the profile of strengths and weaknesses
that underlies one’s behavior and is related to diagnostic classifications, can lead to
tailor-made assessment and indications for treatment, pointing out which aspects need
attention and/or training in one’s self-regulative abilities.
Keywords: executive functioning, dual-diagnosis, comorbidity, substance use disorder, alcohol use disorder,
addiction, schizophrenia, bipolar
INTRODUCTION
In dual-diagnosis, a Substance Use Disorder (SUD) co-occurs with another psychiatric condition
such as psychotic disorder, mood disorder, anxiety disorder or personality disorder (Ziedonis and
Brady, 2005). The Epidemiologic Catchment Area study, a comprehensive study of comorbidity,
showed that the lifetime SUDs-rate in the general population was 17%, compared to 48% for
persons with schizophrenia and 56% for persons with bipolar disorder (Regier et al., 1990). SUD
is described in respectively 27 and 24% of patients with a depressive disorder or an anxiety
disorder (Mueser et al., 2011; Dom et al., 2013). Studying a dual-diagnosis population is relevant,
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because of the threat that SUD and dual-diagnosis form to health,
society, and the presence of relapses in addiction-related behavior
and destructive lifestyles (De Jong et al., 2006; World Health
Organisation [WHO], 2011). In clinical practice dual-diagnosis
frequently occurs whereas ideally distinguishable single disorder
groups are rare. Disorders in dual-diagnosis can have a shared
cause, or can cause/intensify each other’s expression (Mueser
et al., 1998). It is not always easy or possible to distinguish in
which way the disorders causally interact or influence each other.
In most SUDs and other mental disorders self-regulatory
behavior to manage daily life situations (involving work and
relationships) falls short. Coping strategies are impaired,
resulting in affective breakdowns (American Psychiatric
Association, 2013). These frequently observed symptoms of
psychiatric disorders point directly to deficits in executive
functioning (EF) (among others: Barkley, 2001; Egger et al.,
2007; Fernandez-Serrano et al., 2010; Wiers et al., 2012; Janssen,
2013; Luijten et al., 2013; Thoma and Daum, 2013; Goschke,
2014; Smith et al., 2014; Snyder et al., 2015). Executive (dis)-
functioning is currently even seen as a shared underlying key
component of most mental disorders (Egger et al., 2007; Janssen,
2013; Goschke, 2014; Snyder et al., 2015).
Executive functioning can be defined as all cognitive processes
that regulate behavior in such a manner that it can be efficient
and goal-orientated (Miyake et al., 2000; Barkley, 2001; Friedman
et al., 2008; Miyake and Friedman, 2012; Snyder et al., 2015).
Barkley (2001) describes EF as serving to “shift the control
of behavior from the immediate context, social others, and
the temporal now to self-regulation by internal representations
regarding the hypothetical social future”. Miyake et al. (2000)
introduced a model of EF in which three key EF aspects were
presented. Firstly, Shifting concerns the switch of attention
between tasks/operations and/or mental sets. Translated into
daily life, it involves mental flexibility to repeatedly let go of
irrelevant and/or inappropriate behaviors (for example, drug use
or attention bias to alcohol related cues) and switch to more
adequate/relevant behaviors (like sporting or switch of television-
channel). Secondly, Updating involves the process of actively
manipulating and monitoring relevant information in working
memory, in order to keep track of information that is old and
needs actualization (Miyake et al., 2000). For SUD, it can involve
craving. When longing for drugs, a patient may usually tend to
call the drug dealer. But, in a recent relapse prevention session
he or she learned about putting the numbers of supporting
friends in their phone. As this is the first moment of intense
craving after the session and intrusive substance-use thoughts
already come to mind, the patient has to monitor his or her
own behavior and promptly update these thoughts by thinking
of the newly learned information and healthier thoughts. He or
she needs to replace the old information about the drug dealer
with the new information regarding their supportive friend’s
phone number. Inhibition is also needed in this scenario, and it
is defined as the ability to inhibit dominant, automatic responses
when necessary (Miyake et al., 2000; Barkley, 2001). Inhibition
is, for instance, the suppression of approaching alcohol/drugs
and/or calling the drug dealer. Shifting, updating and inhibition
are all needed to some extent when making daily life decisions.
For instance, when one wants to succeed in arriving at work on
time tomorrow, thereby stopping destructive-avoidant behavior
that was linked to one’s SUD lifestyle: (i) shifting is needed to
get up earlier than before and to repeatedly let go of attention
biases triggering late night out fantasies, (ii) inhibition is needed
to prevent this late night ‘going out’ with friends by stopping
yourself from drinking/using and going home, (iii) updating
is involved in checking an alternative work-route, thereby
avoiding and replacing the old, coffee-shop route that would
trigger craving. The interplay between EF aspects can influence
self-regulation in daily life by reducing problem-behavior and
raising more goal-directed behavior. In addition, EF can facilitate
one’s controlled coping with negative feelings and externalizing
problem behaviors like substance-abuse/aggressive outbursts. On
the contrary part, executive dysfunction can cause/aggravate
negative feelings/behavioral outbursts by the perceived lack of
control (Goschke, 2014).
The both unified and diverse aspects of EF can be placed
in a model (Snyder et al., 2015, p. 13). EF can be assessed by
global or more specific neurocognitive tasks (Figure 1 for specific
tasks). If severe executive dysfunctioning is expected, the use of
both global and specific EF tasks is recommended by Snyder
et al. (2015). Inhibition can be measured by Go–NoGo, Stop
Signal, Approach Avoidance Tasks, the Stroop, Anti-saccade,
Event Related Potential components like P300, self-report/rating
measures such as the Frontal Systems Behavioral Scale, BIS-
BAS scales (Behavioral Inhibition System-Behavioral Approach
System) and by the MMPI-2 Impulse-Control index1 (Stroop,
1935; Hallett, 1978; Butcher et al., 1989; Carver and White,
1994; Robbins et al., 1994; Roberts et al., 1994; Rogers and
Monsell, 1995; Mayr and Kliegl, 2000; Grace and Malloy, 2001;
Miyake et al., 2004; Handy, 2005; Franken et al., 2006; Friedman
et al., 2008; Wiers et al., 2009; Wiers et al., 2010). Shifting
can be measured by the Trail Making Test (Reitan, 1958), the
Wisconsin Card Sorting Test (Berg, 1948), and other Category
Switching Tasks. Updating can be measured by the letter memory
task (Morris and Jones, 1990), keep track task (Yntema, 1963)
or spatial n-back task.1 Updating tasks involve monitoring of
incoming information to check task-relevance, and replacement,
update, of old non-relevant information by new information1
(Snyder et al., 2015).
Impairments in EF aspects can trigger the appearance of
mental disorders by several mechanisms such as (i) a failure to
maintain goals when confronted with interfering desires that are
difficult to inhibit and/or complicate shifting to more healthy
goals, (ii) inhibitory impairment of impulsive responses, (iii)
sticking attention to disorder-linked cues like substances that
interfere with adequate shifting, (iv) impaired cognitive control
(inhibition) and distorted anticipational planning, (v) reduced
(emotional) stress regulation, and (vi) cognitive inflexibility
(Goschke, 2014). These mechanisms negatively interfere with
adequate impulse control and decision making, consequently also
thwarting proper self-regulatory behavior in daily life.
Executive functioning impairments were described in
several mental conditions like schizophrenia, bipolar-, anxiety-,
1Most of the tasks are described and categorized in a review by Snyder et al. (2015).
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FIGURE 1 | Unified and diverse aspects of executive functioning (Snyder et al., 2015.)
personality-, developmental disorder, and SUD. For the separate
disorders, a high number of studies have been undertaken and
multiple reviews are present (see, among others, Verdejo-Garcia
et al., 2006; Egger et al., 2007; Fernandez-Serrano et al., 2010;
Wiers et al., 2012; Luijten et al., 2013; Thoma and Daum,
2013; Goschke, 2014; Smith et al., 2014; Snyder et al., 2015).
Elaborating on this, one can expect that in dual-diagnosis EF
will also be impaired. The majority of SUD-patients and half of
schizophrenia/bipolar disorder patients are dually diagnosed.
That makes insight into EF profiles for dual-diagnosis highly
relevant, striving to unravel strengths and pitfalls for daily life
behavior. For instance, the indications for treatment differ if
one’s pitfall primarily is the inhibition of undesired responses,
or a flexible shift from one behavioral strategy to another.
Recommendations for treatment can be formed when one
oversees the differentiated profile of strengths and weaknesses,
particularly in EF.
This article presents an overview of EF studies in dual-
diagnosis.
MATERIALS AND METHODS
The inclusion criteria for studies were as follows: (i) A Method
section that contains information concerning: (a) gender, age,
test-materials and pre-assessment abstinence period of patients,
and (b) diagnostic procedures that were used to determine if a
dual-diagnosis was present or not; (ii) Comparisons by use of
a healthy control group and/or a group without dual-diagnosis;
and (iii) An abstinence period involving less risk for interfering
influence of (sub-) acute substance effects, in order to only
measure residual effects. The substance of study should not be
traceable anymore. Studies with an abstinence period of at least
one week were included. For cannabis, a period of four weeks
was adhered to (for substance detection times see Verstraete,
2004; for interfering effects see Walvoort et al., 2013). Guidelines
for PRISMA analysis were used to select papers (Moher et al.,
2009). PRISMA analysis for Web of Science and PubMed resulted
in 155 papers including the primary search terms of Executive
Functioning AND dual-diagnosis. Four additional papers were
found using other search term-combinations, and two additional
papers were found by other sources such as on topic reviews
(Rabin et al., 2011; Benaiges et al., 2010; Balanza-Martinez
et al., 2015). Consequently, a total of 161 papers were screened
(including duplicates). After screening, 131 papers were excluded
for the following reasons: 121 papers involved the use of search
terms in off-topic contexts: for instance, “dual” in “dual-task”.
Five studies concerned theoretical/qualitative research/reviews
and five papers involved medical/different use of the dual-
diagnosis term. 30 articles were assessed for eligibility. Of these,
19 were excluded after analysis, for the following reasons: 12
papers did not mention abstinence periods, two papers’ method-
sections did not contain gender/age/test materials, one paper was
not found in full-text despite contacting authors and four papers
were duplicates between searches. Finally, a total of 11 studies
were selected based on the criteria (Table 1). Search terms were
Executive Functioning, dual-diagnosis, Substance Use Disorder,
alcohol use disorder, inhibition, updating, shifting, comorbidity,
schizophrenia, bipolar disorder, personality disorder, anxiety
disorder, mood disorder, developmental disorder, and addiction.
The independent variable was the dual-diagnosis; the dependent
variable was the level of functioning on EF tasks.
RESULTS
Findings are presented for 11 studies that involve the dual-
diagnoses of SUD-Schizophrenia (six), SUD-Bipolar disorder
(two), SUD-Personality disorders (two) and SUD-Conduct
disorder (one). For SUD-Anxiety and SUD-Developmental
disorder no studies were found. Results are organized by disorder,
tasks and EF aspect. Significance levels and effect sizes are
described if present (Table 1).
SUD-Schizophrenia
Rodriguez-Jiminez et al. (2010) performed the largest
schizophrenia-SUD dual-diagnosis study, involving 82 patients
with dual-diagnosis (Sch+) and 121 patients with Schizophrenia
without SUD (Sch−). Results mostly showed comparable
Shifting and EF general abilities for Sch+ and Sch−. The
Sch+ group only functioned less at Inhibitory control as
compared to the Sch− group. In two more studies, patients
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with Sch+ and patients with Sch− had similar results for
several shifting tasks (Jockers-Scherübl et al., 2007; Rodriguez-
Jimenez et al., 2008). Contradictory to those findings, two
studies showed better functioning for patients with Sch+ as
compared to Sch− on shifting abilities (Schnell et al., 2009;
Benaiges et al., 2013). Furthermore, in one study, patients
with Sch+ functioned less adequate at shifting (Trail Making
Test) and inhibition tasks than patients with Sch− (Jockers-
Scherübl et al., 2007). Lastly, Sevy et al., 2007; including a
healthy control group) showed worse shifting abilities for Sch+
patients (schizophrenia-cannabis) as compared to healthy
controls.
SUD-Bipolar Mood Disorder
Patients with SUD-bipolar disorder showed poorer functioning
on mental shifting ability as compared to healthy controls,
measured by the Wisconsin Card Sorting Test. That is, dual-
diagnosis patients completed fewer categories than controls (Van
Gorp et al., 1998). Marshall et al. (2012) described that patients
with SUD-bipolar disorder had more executive (inhibitory
control, set-shifting, and interference resolution) dysfunctions
than controls and patients with bipolar disorder without
SUD.
SUD-Personality Disorders
In 2013 and 2014, cocaine abusing patients with cluster B
(borderline, narcissistic, histrionic, and anti-social) and cluster
C (avoidant, dependent, and obsessive compulsive) personality
disorders were studied at diverse EF. Patients with SUD-cluster B
personality disorders, that is, more impulsive personality types,
showed impairments in nearly all EF aspects as compared to
controls and most specifically in inhibitory control. Patients with
SUD-cluster C personality disorders, that is, more inhibited and
obsessive personality types, showed more problems in working
memory and updating ability. Patients with SUD as compared to
the dual-diagnosis group had a better inhibitory control. However,
compared to healthy controls, the SUD group also showed
impairments in shifting and working memory. Patients with dual-
diagnosis SUD-Personality disorders as a group consistently
functioned less on shifting, updating and inhibitory abilities as
compared to healthy controls (Albein-Urios et al., 2013; Albein-
Urios et al., 2014).
SUD-Conduct Disorder
One study compared 239 females with dual-diagnosis to
healthy controls. Impairments were shown for the dual-
diagnosis group on inhibition and planning ability as
compared to healthy controls (Giancola and Mezzich,
2000).
SUD-Anxiety Disorders, Developmental
Disorders
Despite frequent co-occurrence of SUD-anxiety or SUD-
developmental disorders (for prevalence numbers see Dom et al.,
2013), we found no studies on EF for these groups.
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DISCUSSION
Aim and Model
Aim and Model Gaining a prototypical profile of EF for dual-
diagnosis. This is expected to contribute to tailor-made directions
for treatment.
Findings
Findings Shifting and inhibitory control mostly are compromised
in patients with dual-diagnosis as compared to healthy controls.
If one were to think of dual-diagnosis and its overt behavioral
symptoms, it is quite conceivable that dual-diagnosis implicates
a high amount of (affective) turbulence and sensory sensitivity,
since both substances and psychotic/bipolar/other symptoms
have an interfering influence on the balance of several brain
processes. Elaborating on this, maintaining a realistic view of
daily life situations with flexible participation and properly timed
inhibition when needed, is likely to be impaired. As compared
to Sch−, patients with Sch+ show less inhibitory control. One
possible explanation for this difference may be that patients
with a SUD-combination show relatively more impulsivity, partly
because the use of substances may negatively influence their
dopaminergic inhibitory brain processes. Thereby, they seem
to be less capable of inhibiting desires than patients without
SUD. Furthermore, with a view to negative symptomatology, the
schizophrenia patient-group is possibly more avoidant/inhibited
than approaching in behavior manner. In terms of impulsivity,
this hypothetical explanation also applies to the finding that
patients with cluster B (impulsive type) personality disorder
and SUD perform inhibitory control tasks less adequately than
patients with only SUD. Whereas impulsive behavior has
shown to negatively interfere with inhibitory control, it can
also be influenced vice versa: common impulsive behavior
in dual-diagnoses such as SUD-Bipolar disorder, SUD-cluster
B Personality disorder and SUD-Conduct disorder (American
Psychiatric Association, 2013) may be maintained or even urged
by executive impairments. Impulsivity however seems to have
a positive counterpart as well: the finding that Sch+ patients
function slightly better on shifting abilities than Sch− patients
may be linked to a higher tendency for impulsiveness and search
for novelty in patients with SUD-combinations. This means that
a flexible switch from familiar pathways to other routes may
be easier for persons that are more impulsive and less rigid in
behavior than for more avoidant persons that may seek and/or
persevere in familiar styles of behavior.
Limitations Concerning Dual-Diagnosis
Research
Some conflicting findings reduce the certainty with which
conclusions can be stated. These contradictions may be partly
caused by factors that influenced several studies, and that
may have restricted the validity and reliability of the observed
empirical findings in those studies. For instance, the study of
Jockers-Scherübl et al. (2007), that of Schnell et al. (2009) and
that of Sevy et al. (2007) involved differences in education
levels between the Sch+ (lower education level) and Sch−
group. Furthermore, in one study the Sch+ group included
younger patients and involved more males than the Sch−
group. The differences in age actually showed to be a factor
in differences found between the groups; so the observed
weakened inhibitory control may be affected by the younger
age of the dual-diagnosis group (study of Rodriguez-Jiminez
et al., 2010). Complications in dual-diagnosis research are
possibly due to several reasons. Sample sizes are mostly modest
because it is difficult to recruit patients that (i) are in a
mild psychiatric state needed for sufficient testability, (ii) are
motivated to cooperate and stop using substances, and (iii)
have achieved substance-abstinence for a reasonable time prior
to assessment, ideally confirmed by tests. A pre-assessment
abstinence period of at least six weeks is best, in case of
alcohol, but probably for other substances as well, due to the
recovery that the body undergoes in this period of time (Weeda
et al., 2006; Walvoort et al., 2013). The length of substance
abstinence and methods are not always clearly documented,
which reduces the validity and reliability of conclusions.
Furthermore, when testing patients with dual-diagnosis, it
is not clear which disorder and/or substance contributes
to which specific empirical finding (Balanza-Martinez et al.,
2015). Partly for that reason, disorders and substances are
usually studied “separately”. But procedures for dual-diagnosis
presence are not always described. This makes it ambiguous
whether separate disorders or dual-diagnosis is studied. For
example, Giancola and Mezzich (2000) described a “SUD
without dual-diagnosis” group in which no Conduct Disorder
was present (2000); however, other psychiatric diagnoses were
present in this “SUD” group, making it still a “dual-diagnosis”
group.
Future Research
Findings lead to the following future research recommendations.
Firstly, studying dual-diagnosis has value, when methods
are described in a valid manner. Secondly, sufficiently long
abstinence periods before assessment, preferably approximately
6 weeks, should be attained to prevent findings from being
influenced by acute or sub-acute substance use effects (Weeda
et al., 2006; Walvoort et al., 2013). Thirdly, the use of
healthy control groups is highly recommended to enable
valid comparisons. Fourthly, studies need to be performed in
patient groups that also exist in clinical practice, such as dual-
diagnosis involving anxiety and developmental disorders. Fifthly,
research on all diverse aspects of EF is recommended, also
involving Updating processes/working memory. Impairments in
flexible shifting abilities, updating processes, or impairments in
inhibitory control over undesired responses will most probably
lead to different indications for treatment. Finally, findings
as described should get more strength through follow up
research, including the test of the stated impulsivity hypothesis.
Elaborating on these recommendations, there are promising
results regarding EF treatment interventions, for instance with
Dys-executive Syndrome Treatment Programs and Approach-
Avoidance/Inhibitory Intervention Training (among others,
Boelen et al., 2012; Rinck et al., 2013; Sharbanee et al., 2014).
Hence, unraveling EF in dual-diagnosis has great value for
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coaching and treatment of patients, and it illustrates how the gap
between neuroscience and psychotherapy can be bridged.
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